128 related articles for article (PubMed ID: 30081104)
1. Niclosamide ethanolamine improves kidney injury in db/db mice.
Han P; Zhan H; Shao M; Wang W; Song G; Yu X; Zhang C; Ge N; Yi T; Li S; Sun H
Diabetes Res Clin Pract; 2018 Oct; 144():25-33. PubMed ID: 30081104
[TBL] [Abstract][Full Text] [Related]
2. Niclosamide ethanolamine improves diabetes and diabetic kidney disease in mice.
Han P; Shao M; Guo L; Wang W; Song G; Yu X; Zhang C; Ge N; Yi T; Li S; Du H; Sun H
Am J Transl Res; 2018; 10(4):1071-1084. PubMed ID: 29736201
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes.
Hinder LM; Sas KM; O'Brien PD; Backus C; Kayampilly P; Hayes JM; Lin CM; Zhang H; Shanmugam S; Rumora AE; Abcouwer SF; Brosius FC; Pennathur S; Feldman EL
Sci Rep; 2019 Jan; 9(1):881. PubMed ID: 30696927
[TBL] [Abstract][Full Text] [Related]
4. Niclosamide ethanolamine inhibits artery constriction.
Li SL; Yan J; Zhang YQ; Zhen CL; Liu MY; Jin J; Gao JL; Xiao XL; Shen X; Tai Y; Hu N; Zhang XZ; Sun ZJ; Dong DL
Pharmacol Res; 2017 Jan; 115():78-86. PubMed ID: 27872020
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
[TBL] [Abstract][Full Text] [Related]
6. Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice.
Guo J; Tao H; Alasadi A; Huang Q; Jin S
Eat Weight Disord; 2019 Feb; 24(1):91-96. PubMed ID: 28780747
[TBL] [Abstract][Full Text] [Related]
7. Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice.
Tao H; Zhang Y; Zeng X; Shulman GI; Jin S
Nat Med; 2014 Nov; 20(11):1263-9. PubMed ID: 25282357
[TBL] [Abstract][Full Text] [Related]
8. Niclosamide ethanolamine protects kidney in adriamycin nephropathy by regulating mitochondrial redox balance.
Han P; Yuan C; Wang Y; Wang M; Weng W; Zhan H; Yu X; Wang T; Li Y; Yi W; Shao M; Li S; Yi T; Sun H
Am J Transl Res; 2019; 11(2):855-864. PubMed ID: 30899385
[TBL] [Abstract][Full Text] [Related]
9. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM
Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224
[TBL] [Abstract][Full Text] [Related]
10. Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway.
Pei X; Zheng F; Li Y; Lin Z; Han X; Feng Y; Tian Z; Ren D; Cao K; Li C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159160
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
Lin Y; Sun Z
J Endocrinol; 2011 May; 209(2):185-91. PubMed ID: 21307121
[TBL] [Abstract][Full Text] [Related]
12. Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type 2 diabetes.
Takenaka T; Kobori H; Miyazaki T; Suzuki H; Nishiyama A; Ishii N; Yamashita M; Hayashi M
Acta Physiol (Oxf); 2019 Feb; 225(2):e13190. PubMed ID: 30251773
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes.
El Boustany R; Taveau C; Chollet C; Velho G; Bankir L; Alhenc-Gelas F; Roussel R; Bouby N
J Diabetes Complications; 2017 Jun; 31(6):929-932. PubMed ID: 28412033
[TBL] [Abstract][Full Text] [Related]
14. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes.
Sourris KC; Harcourt BE; Tang PH; Morley AL; Huynh K; Penfold SA; Coughlan MT; Cooper ME; Nguyen TV; Ritchie RH; Forbes JM
Free Radic Biol Med; 2012 Feb; 52(3):716-723. PubMed ID: 22172526
[TBL] [Abstract][Full Text] [Related]
15. Niclosamide ethanolamine attenuates systemic lupus erythematosus and lupus nephritis in MRL/lpr mice.
Han P; Weng W; Chen Y; Cai Y; Wang Y; Wang M; Zhan H; Yuan C; Yu X; Shao M; Sun H
Am J Transl Res; 2020; 12(9):5015-5031. PubMed ID: 33042403
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
17. 2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.
Ichinose K; Maeshima Y; Yamamoto Y; Kinomura M; Hirokoshi K; Kitayama H; Takazawa Y; Sugiyama H; Yamasaki Y; Agata N; Makino H
Diabetes; 2006 May; 55(5):1232-42. PubMed ID: 16644677
[TBL] [Abstract][Full Text] [Related]
18. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV ameliorates renal injury in db/db mice.
Sun H; Wang W; Han P; Shao M; Song G; Du H; Yi T; Li S
Sci Rep; 2016 Sep; 6():32545. PubMed ID: 27585918
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy.
Sharkovska Y; Reichetzeder C; Alter M; Tsuprykov O; Bachmann S; Secher T; Klein T; Hocher B
J Hypertens; 2014 Nov; 32(11):2211-23; discussion 2223. PubMed ID: 25215436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
